Read the news carefully.
FDA said their treatment was safe, not effective. One study does say it adds 4.5 months of life expectancy.
Be careful. I'm not saying it won't skyrocket, but you better be careful.
Here's my paid-for subscription newsfeed for everyone.
FDA Panel: Dendreon Prostate Cancer Drug Is Safe
16 minutes ago - Dow Jones News
By Jennifer Corbett Dooren
Of DOW JONES NEWSWIRES WASHINGTON -(Dow Jones)- A Food and Drug Administration panel said Thursday that a proposed prostate-cancer treatment from Dendreon Corp. (DNDN) is safe.
However, the panel is now voting on a question about whether the drug is effective, and that vote will be the key vote in determining whether the panel thinks the FDA should approve the drug.
The FDA said two studies of Provenge showed it failed to meet a study goal of reducing so-called time to progression, or the advancement of cancer. However, a subsequent analysis of one of the studies, which involved a total of 127 men, showed those receiving Provenge lived about 4.5 months longer than men not receiving the drug.
Unlike existing cancer treatments, Provenge is considered a therapeutic vaccine that is made using a patient's own white blood cells, combined with a protein and then infused back into a person. The treatment is designed to stimulate the body's immune system to fight the cancer. Existing therapies are aimed at killing cancer cells or choking off blood supply and other proteins involved in cancer growth.
-By Jennifer Corbett Dooren, Dow Jones Newswires; 202-862-9294; ]